15May 2021
Immunotherapy biomarkers: the long and winding road

Immunotherapy biomarkers: the long and winding road

A recent meta-analysis examined and validated biomarkers of response to immune-checkpoint inhibitors (ICIs). Herein, we discuss the findings of this analysis, which are consistent with previously identified determinants of ICI efficacy and demonstrate that some genetic variables influence response across multiple cancer types.

  • #oncology

Like

Save

Share